These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 6379506)

  • 1. A double-blind controlled trial of bovine brain gangliosides in amyotrophic lateral sclerosis.
    Bradley WG; Hedlund W; Cooper C; Desousa GJ; Gabbai A; Mora JS; Munsat TL; Scheife R
    Neurology; 1984 Aug; 34(8):1079-82. PubMed ID: 6379506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ganglioside therapy for amyotrophic lateral sclerosis: a double-blind controlled trial.
    Harrington H; Hallett M; Tyler HR
    Neurology; 1984 Aug; 34(8):1083-5. PubMed ID: 6379507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A double-blind, placebo-controlled trial of high doses of gangliosides in amyotrophic lateral sclerosis.
    Lacomblez L; Bouche P; Bensimon G; Meininger V
    Neurology; 1989 Dec; 39(12):1635-7. PubMed ID: 2685660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Double-blind controlled trial of purified brain gangliosides in amyotrophic lateral sclerosis and experience with peripheral neuropathies.
    Bradley WG
    Adv Exp Med Biol; 1984; 174():565-73. PubMed ID: 6331136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trial of octacosanol in amyotrophic lateral sclerosis.
    Norris FH; Denys EH; Fallat RJ
    Neurology; 1986 Sep; 36(9):1263-4. PubMed ID: 3528918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trials of ganglioside therapy for amyotrophic lateral sclerosis and diabetic neuropathy.
    Hallett M; Harrington H; Tyler HR; Flood T; Slater N
    Adv Exp Med Biol; 1984; 174():575-9. PubMed ID: 6377851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized, double-blind, controlled trial of acetylcysteine in amyotrophic lateral sclerosis.
    Louwerse ES; Weverling GJ; Bossuyt PM; Meyjes FE; de Jong JM
    Arch Neurol; 1995 Jun; 52(6):559-64. PubMed ID: 7763202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and efficacy of rasagiline as an add-on therapy to riluzole in patients with amyotrophic lateral sclerosis: a randomised, double-blind, parallel-group, placebo-controlled, phase 2 trial.
    Ludolph AC; Schuster J; Dorst J; Dupuis L; Dreyhaupt J; Weishaupt JH; Kassubek J; Weiland U; Petri S; Meyer T; Grosskreutz J; Schrank B; Boentert M; Emmer A; Hermann A; Zeller D; Prudlo J; Winkler AS; Grehl T; Heneka MT; Wollebæk Johannesen S; Göricke B;
    Lancet Neurol; 2018 Aug; 17(8):681-688. PubMed ID: 29934198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dexpramipexole versus placebo for patients with amyotrophic lateral sclerosis (EMPOWER): a randomised, double-blind, phase 3 trial.
    Cudkowicz ME; van den Berg LH; Shefner JM; Mitsumoto H; Mora JS; Ludolph A; Hardiman O; Bozik ME; Ingersoll EW; Archibald D; Meyers AL; Dong Y; Farwell WR; Kerr DA;
    Lancet Neurol; 2013 Nov; 12(11):1059-67. PubMed ID: 24067398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Short-term double-blind vs placebo trial of L-threonine in amyotrophic lateral sclerosis].
    Blin O; Serratrice G; Pouget J; Aubrespy G; Guelton C; Crevat A
    Presse Med; 1989 Sep; 18(30):1469-70. PubMed ID: 2534171
    [No Abstract]   [Full Text] [Related]  

  • 11. A double-blind study of the effectiveness of cyclosporine in amyotrophic lateral sclerosis.
    Appel SH; Stewart SS; Appel V; Harati Y; Mietlowski W; Weiss W; Belendiuk GW
    Arch Neurol; 1988 Apr; 45(4):381-6. PubMed ID: 3281637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gangliosides--clinical overview.
    DeFelice SL; Ellenberg M
    Adv Exp Med Biol; 1984; 174():625-8. PubMed ID: 6377854
    [No Abstract]   [Full Text] [Related]  

  • 13. A double-blind, placebo-controlled trial of TRH in amyotrophic lateral sclerosis.
    Caroscio JT; Cohen JA; Zawodniak J; Takai V; Shapiro A; Blaustein S; Mulvihill MN; Loucas SP; Gudesblatt M; Rube D
    Neurology; 1986 Feb; 36(2):141-5. PubMed ID: 3080693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A double-blind placebo-controlled clinical trial of subcutaneous recombinant human ciliary neurotrophic factor (rHCNTF) in amyotrophic lateral sclerosis. ALS CNTF Treatment Study Group.
    Neurology; 1996 May; 46(5):1244-9. PubMed ID: 8628460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND).
    Miller RG; Mitchell JD; Lyon M; Moore DH
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2003 Sep; 4(3):191-206. PubMed ID: 13129806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Controlled trial of thyrotropin releasing hormone in amyotrophic lateral sclerosis.
    Brooke MH; Florence JM; Heller SL; Kaiser KK; Phillips D; Gruber A; Babcock D; Miller JP
    Neurology; 1986 Feb; 36(2):146-51. PubMed ID: 3080694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Double-blind controlled trials of Cronassial in chronic neuromuscular diseases and ataxia.
    Bradley WG; Badger GJ; Tandan R; Fillyaw MJ; Young J; Fries TJ; Krusinski PB; Witarsa M; Boerman J; Blair CJ
    Neurology; 1988 Nov; 38(11):1731-9. PubMed ID: 2847079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amyotrophic lateral sclerosis: a double-blind crossover trial of thyrotropin-releasing hormone.
    Imoto K; Saida K; Iwamura K; Saida T; Nishitani H
    J Neurol Neurosurg Psychiatry; 1984 Dec; 47(12):1332-4. PubMed ID: 6439824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A double-blind placebo-controlled trial of L-threonine in amyotrophic lateral sclerosis.
    Blin O; Pouget J; Aubrespy G; Guelton C; Crevat A; Serratrice G
    J Neurol; 1992 Feb; 239(2):79-81. PubMed ID: 1313078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trial of oral physostigmine in amyotrophic lateral sclerosis.
    Norris FH; Tan Y; Fallat RJ; Elias L
    Clin Pharmacol Ther; 1993 Dec; 54(6):680-2. PubMed ID: 8275623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.